(C099) Amundi Bloomberg - Ratings and Ratios
Energy, Metals, Industrial Commodities, Exclude Agriculture
Description: C099 Amundi Bloomberg
The Amundi Bloomberg Equal-weight Commodity ex-Agriculture UCITS ETF Euro Hedged Acc is a German-originated ETF that provides diversified exposure to a broad basket of commodities, excluding agricultural products. This fund is designed to track the Bloomberg Equal Weight Commodity ex-Agri Index, offering a euro-hedged accumulation share class.
By excluding agricultural commodities, this ETF focuses on energy, metals, and other industrial commodities, potentially providing a unique investment opportunity for those seeking to capitalize on trends in these sectors. The equal-weight methodology employed by the underlying index ensures that no single commodity dominates the portfolio, thereby reducing concentration risk.
From a technical analysis perspective, the ETFs price action indicates a bullish trend, with the short-term Simple Moving Average (SMA20) at 26.29 surpassing the longer-term SMAs (SMA50 at 25.82 and SMA200 at 25.92). The Average True Range (ATR) of 0.26, representing a 0.96% daily volatility, suggests relatively stable price movements. Given the current price of 27.39, proximity to the 52-week high of 27.50, and the upward sloping moving averages, a potential forecast could be a continued upward trajectory, potentially testing new highs.
Fundamentally, the ETFs Assets Under Management (AUM) stand at 1547.22 million EUR, indicating a significant investor base and liquidity. Considering the commodity markets tendency to be influenced by macroeconomic factors, geopolitical events, and supply-demand imbalances, the exclusion of agricultural commodities might make this ETF less susceptible to food price shocks, potentially offering a more stable commodity exposure.
Combining technical and fundamental insights, a forecast for the Amundi Bloomberg Equal-weight Commodity ex-Agriculture UCITS ETF Euro Hedged Acc could be cautiously optimistic. If the current bullish trend continues, driven by favorable commodity prices and maintained investor interest (as indicated by substantial AUM), the ETF might edge closer to or surpass its 52-week high. However, any forecast is contingent upon broader market conditions, including economic indicators, geopolitical stability, and commodity-specific supply chain dynamics.
Additional Sources for C099 ETF
C099 ETF Overview
Market Cap in USD | 1,826m |
Category | Commodities - Broad Basket |
TER | 0.35% |
IPO / Inception | 2019-02-21 |
C099 ETF Ratings
Growth Rating | 19.6 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 2.65 |
Analysts | - |
Fair Price Momentum | 24.73 EUR |
Fair Price DCF | - |
C099 Dividends
Currently no dividends paidC099 Growth Ratios
Growth Correlation 3m | 93.2% |
Growth Correlation 12m | 56% |
Growth Correlation 5y | 38.3% |
CAGR 5y | 1.22% |
CAGR/Max DD 5y | 0.08 |
Sharpe Ratio 12m | 0.91 |
Alpha | -4.57 |
Beta | 0.473 |
Volatility | 16.09% |
Current Volume | 2.5k |
Average Volume 20d | 4.8k |
As of July 06, 2025, the stock is trading at EUR 27.58 with a total of 2,457 shares traded.
Over the past week, the price has changed by +1.04%, over one month by +5.34%, over three months by +10.54% and over the past year by +2.43%.
Neither. Based on ValueRay´s Analyses, Amundi Bloomberg is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 19.56 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of C099 is around 24.73 EUR . This means that C099 is currently overvalued and has a potential downside of -10.33%.
Amundi Bloomberg has no consensus analysts rating.
According to our own proprietary Forecast Model, C099 Amundi Bloomberg will be worth about 27.7 in July 2026. The stock is currently trading at 27.58. This means that the stock has a potential upside of +0.44%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 27.7 | 0.4% |